BIOMAT Database Logo BIOMAT Database Logo

Conversion of long-term renal allograft recipients from prednisolone/azathioprine to cyclosporine monotherapy. 1988

S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Tissue Culture Laboratory, University Hospital of Odense, Denmark.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
February 1987, Transplantation proceedings,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Conversion from cyclosporine to azathioprine in renal allograft recipients.
December 1984, Transplantation,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
August 1985, Transplantation proceedings,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Conversion of immunosuppression in renal allograft recipients from cyclosporine A to azathioprine and prednisolone 6 months after transplantation.
October 1987, Transplantation proceedings,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
February 1987, Transplantation proceedings,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Conversion from cyclosporine to azathioprine in renal graft recipients.
August 1985, Transplantation proceedings,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Conversion from cyclosporin to azathioprine in renal allograft recipients.
September 1991, East African medical journal,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
June 1988, Transplantation proceedings,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Renal allograft biopsy and conversion of cyclosporine to azathioprine.
February 1989, Transplantation,
S A Birkeland, and N Foged, and A A Kold, and V Svendsen, and N Rohr, and A Elbirk
Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
February 1988, Transplantation proceedings,
Copied contents to your clipboard!